HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

polyacrylonitrile (Orlon)

Also Known As:
Orlon; poly(acrylonitrile); 2-Propenenitrile, homopolymer
Networked: 120 relevant articles (6 outcomes, 13 trials/studies)

Relationship Network

Drug Context: Research Results

Experts

1. Frey, Peter: 2 articles (06/2010 - 02/2007)
2. Ramseyer, Pascal: 2 articles (06/2010 - 02/2007)
3. Ali, Fedaa: 1 article (05/2022)
4. Amin, Rehab: 1 article (05/2022)
5. ElShehaby, Hasnaa A: 1 article (05/2022)
6. Emam, Merna H: 1 article (05/2022)
7. Kamoun, Elbadawy A: 1 article (05/2022)
8. Kasry, Amal: 1 article (05/2022)
9. Loutfy, Samah A: 1 article (05/2022)
10. Nageh, Hassan: 1 article (05/2022)

Related Diseases

1. Shock
2. Critical Illness (Critically Ill)
3. Acute Kidney Injury (Acute Renal Failure)
05/01/1981 - "A patient with fulminant hepatic encephalopathy and acute renal failure progressively deteriorated following daily hemodialysis with a hollow fiber artificial kidney improved dramatically after an initial dialysis with a polyacrylonitrile membrane system. "
08/27/1994 - "The cuprophane group had a lower survival rate (38 vs 65%), a higher proportion of patients dying from sepsis (71 vs 40%), required more haemodialysis sessions (12 vs 9), and demonstrated delayed resolution and recovery from acute renal failure than the polyacrylonitrile group. "
12/01/1991 - "On subsequent days, groups of rats with acute renal failure were exposed to daily zymosan infusion (an activator of the complement system), or to blood incubated with cuprophane (CUP) or polyacrylonitrile (PAN) dialysis membranes. "
03/01/2000 - "In 10 critically ill patients with acute renal failure, the efficiency of four hollow-fiber hemofilters, polyamide 0.6 m(2), polyacrylonitrile (PAN) 0.3 and 0.6 m(2), acrylonitrile sodium methallylsulfonate (AN69HF) 0.6 m(2), has been evaluated. "
04/01/1992 - "To develop a continuous arteriovenous hemofiltration (CAVH) system, which does not need systemic anticoagulation, for patients of acute renal failure having bleeding tendencies, a totally antithrombogenic continuous ultrafiltration system (ACUS) was designed, which consists of an antithrombogenic polyacrylonitrile-polyethyleneoxide (PAN-PEO) hollow fiber membrane and ionically heparin-bound catheter, tubing, and module header. "
4. Hepatic Encephalopathy
5. Inflammation (Inflammations)

Related Drugs and Biologics

1. cuprammonium cellulose
2. polysulfone P 1700 (UDEL)
3. Polymethyl Methacrylate (Sol)
4. Cellulose
5. Hydrogels
6. AN-69 (AN 69)
7. Heparin (Liquaemin)
8. Acetates (Acetic Acid Esters)
9. Dialysis Solutions
10. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)

Related Therapies and Procedures

1. Renal Dialysis (Hemodialysis)
2. Artificial Kidneys
3. Hemofiltration
4. Continuous Renal Replacement Therapy
5. Injections